6141c2946e5e14dda11835a6ed441844

COBAS HBV (VIRUS DE LA HEPATITIS B)

ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO)·III·Colombia INVIMA·Expires November 22, 2027

Device classification

Risk class / Clase de Riesgo: III
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 6141c2946e5e14dda11835a6ed441844
Expire date: November 22, 2027

Authorized company / Fabricante

Name (Spanish): ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO)
Name (English): ROCHE DIAGNOSTICS GMBH (FINISHED PRODUCT MANUFACTURER)

Product use / Uso del Producto

Spanish

PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL VIRUS DE LA HEPATITIS B (VHB) EN PLASMA HUMANO CONSERVADO EN EDTA O SUERO DE PACIENTES INFECTADOS CON EL VHB.

English

IN VITRO NUCLEIC ACID AMPLIFICATION TEST FOR THE QUANTIFICATION OF THE DNA OF THE VIRUS OF THE HEPATITIS B (HBV) IN PRESERVED HUMAN PLASMA IN EDTA OR SERUM FROM PATIENTS INFECTED WITH THE HBV.

About this record

Access comprehensive regulatory information for COBAS HBV (VIRUS DE LA HEPATITIS B) (COBAS HBV (VIRUS DE LA HEPATITIS B)) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 6141c2946e5e14dda11835a6ed441844 and manufactured by ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO). The device was registered on November 22, 2027.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.